Instrument Inactif

Autres langues RLS Global AB (publ)

Actions

RLS Global to Submit Bankruptcy Application	20/11
RLS Global ansöker om konkurs	20/11
RLS Global Abandons ChloraSolv Partnership with ConvaTec Group	10/11
RLS Global Launches Strategic Review of Options for ChloraSolv Commercialization	10/11
RLS Global initiates strategic review process aiming to commercialize ChloraSolv	09/11
RLS Global Initiates Strategic Review Process Aiming to Commercialize ChloraSolv	09/11
RLS Global and Convatec have agreed to terminate collaboration agreement	09/11
RLS Global and Convatec Agree to Terminate Collaboration Agreement	09/11
RLS Global Enrols First Patient in Clinical Trial on Pressure Ulcers	06/09/23
First patient included in new clinical investigation on pressure ulcers	06/09/23
RLS Global AB Announces First Patient Included in New Clinical Investigation on Pressure Ulcers	06/09/23
ChloraSolv recommended for UK CA certification required for UK market after Brexit	01/09/23
RLS Global Q2 2023 - Uncertain future	28/08/23
RLS GLOBAL AB (publ) PUBLISHES INTERIM REPORT FOR THE PERIOD APRIL-JUNE 2023	25/08/23
RLS Global AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	25/08/23
RLS Global Receives SEK5 Million Loan	25/08/23
RLS GLOBAL AB (PUBL) RAISES A SHORT-TERM LOAN OF MSEK 5.0	24/08/23
RLS Global Names New CFO	22/08/23
RLS Global appoints Torbjörn Sannerstedt as new Chief Financial Officer	22/08/23
RLS Global AB Announces Chief Financial Officer Changes	22/08/23

Aucun résultat pour cette recherche